Navigation Links
Relief from Migraine

Participants in a migraine medication study who cheated and took the drug earlier than suggested may have done migraine sufferers everywhere a big favor.//

A new study shows the medication works best when taken at the first sign of pain, rather than waiting until pain is moderate to severe, as was the requirement of the original study.

Previous research on the use of drugs known as serotonin agonists for the treatment of migraine have required patients to take the drugs only when their pain reached moderate to severe levels. However, patients in one study on the drug sumatriptan violated this rule, taking the medication as soon as they felt a migraine coming on. Researchers analyzed their results separately, and noted treatment of mild pain may be a better strategy.

Investigators conducted two identical studies to see if using sumatriptan for mild pain had the desired effects. The first study involved 354 patients and the second involved 337 patients. Patients were randomized to receive either the active drug or a placebo. Results showed significantly better pain control among those taking the active drug in either 50 milligram or 100 milligram doses. Fifty percent of those taking the lower dose and 57 percent taking the higher dose reported they were completely free from pain two hours later, compared to 29 percent of those taking the placebo. At four hours, 61 percent and 68 percent, respectively, were free from pain, compared to 30 percent for the placebo. Similar numbers were found when the researchers measured freedom from both pain and other migraine symptoms at two and four hours.
'"/>




Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Relief from common back pain
3. Relief to pregnant women using fertility drugs
4. Relief of pain for suffering patients
5. Relief from cancer pain with anticonvulsants
6. Pain Relief For Osteoarthritis Patients
7. Relief From Migraines
8. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Relief For Women Suffering From Fibromyalgia
11. Lemons Could Give Relief For Patients Suffering From Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: